Exempt Chemical Preparations Under the Controlled Substances Act
DEA published a list of approved and denied exempt chemical preparation applications received between July 1, 2025, and March 31, 2026. Businesses must verify their products' status and ensure compliance with exemption criteria.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Manufacturers, distributors, and dispensers of chemical preparations that may qualify for exemption from the Controlled Substances Act. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; action should be taken promptly to avoid inadvertent non-compliance.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA has approved or denied specific exempt chemical preparation applications for the period July 1, 2025 – March 31, 2026. The list indicates which preparations are now officially exempt or not.
Who it affects
Manufacturers, distributors, and dispensers of chemical preparations that may qualify for exemption from the Controlled Substances Act.
What you must do
Review the published list to confirm whether your products are included as approved exempt preparations. If denied, ensure compliance with full CSA requirements.
Deadline
Not specified; action should be taken promptly to avoid inadvertent non-compliance.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law increases access to birth control at pharmacies - WGME
- Andrew Jonathan Morgan: Final Debarment Order
- SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams
- Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
- Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal